王悠清. 2020年全球癌症统计报告[J]. 中华预防医学杂志，2021，55（3）：398.

WANG Y Q. Global cancer statistics report 2020[J]. Chin J Prev Med，2021，55（3）：398.

郭兰伟，张兴龙，蔡林，等. 全球结直肠癌流行和防控现状 [J]. 中华肿瘤杂志，2024，46（1）：57-65.

GUO L W，ZHANG X L，CAI L，et al. Current status of global colorectal cancer prevalence，prevention and control[J]. Chin J Oncol，2024，46（1）：57-65.

FONG W，LI Q，YU J. Gut microbiota modulation：a novel strategy for prevention and treatment of colorectal cancer[J]. Oncogene，2020，39（26）：4925-4943.

GOU H Y，SU H，LIU D H，et al. Traditional medicine Pien Tze Huang suppresses colorectal tumorigenesis through restoring gut microbiota and metabolites[J]. Ga- stroenterology，2023，165（6）：1404-1419.

ASADZADEH AGHDAEI H，REZASOLTANI S，OLFATIFAR M，et al. Expression of toll-like receptors 2，4 and 5 in relation to gut microbiota in colon neoplasm patients with and without inflammatory bowel disease[J]. Avicenna J Med Biotechnol，2022，14（3）：188-195.

LUCAS C，BARNICH N，NGUYEN H T T. Microbiota，inflammation and colorectal cancer[J]. Int J Mol Sci，2017，18（6）：1310.

BAI X，DUAN Z G，DENG J J，et al. Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism[J]. J Adv Res，2024：S2090-S1232（24）00265-0.

CZENE K，LICHTENSTEIN P，HEMMINKI K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database[J]. Int J Cancer，2002，99（2）：260-266.

KONISHI Y，OKUMURA S，MATSUMOTO T，et al. Development and evaluation of a colorectal cancer screening method using machine learning-based gut microbiota analysis[J]. Cancer Med，2022，11（16）：3194-3206.

IADSEE N，CHUAYPEN N，TECHAWIWATTANABOON T，et al. Identification of a novel gut microbiota signature associated with colorectal cancer in Thai population[J]. Sci Rep，2023，13（1）：6702.

CHEN Z F，AI L Y，WANG J L，et al. Probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis[J]. Future Microbiol，2015，10（9）：1433-1445.

OH N S，LEE J Y，KIM Y T，et al. Cancer-protective effect of a synbiotic combination between Lactobacillus gasseri 505 and a Cudrania tricuspidata leaf extract on colitis-associated colorectal cancer[J]. Gut Microbes，2020，12（1）：1785803.

QU R Z，ZHANG Y，MA Y P，et al. Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer[J]. Adv Sci，2023，10（23）：e2205563.

刘丽. 肠道菌群失调与胆汁酸代谢紊乱在结肠炎相关肠癌中的作用[D]. 天津：天津医科大学，2019.

LIU L. The role of intestinal flora imbalance and bile acid metabolism disorder in colitis-related intestinal cancer[D]. Tianjin：Tianjin Medical University，2019.

GOMES S D，OLIVEIRA C S，AZEVEDO-SILVA J，et al. The role of diet-related short-chain fatty acids in colorectal cancer metabolism and survival：prevention and therapeutic implications[J]. Curr Med Chem，2020，27（24）：4087-4108.

祝贺. 口服抗肿瘤药物对小鼠肠道菌群和免疫相关基因表达的影响[D]. 济南：山东师范大学，2016.

ZHU H. Effects of oral anti-tumor drugs on intestinal flora and immune-related gene expression in mice[D]. Jinan：Shandong Normal University，2016.

梁志，乌日嘎，李鹏达，等. 口服益生菌对结直肠癌化疗患者肠道菌群影响的Meta分析 [J]. 包头医学院学报，2023，39（3）：32-36.

LIANG Z，Wuriga，LI P D，et al. Meta-analysis of the effect of oral probiotics on intestinal flora in patients with colorectal cancer undergoing chemotherapy[J]. J Baotou Med Coll，2023，39：32-36.

YU T，GUO F F，YU Y N，et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy[J]. Cell，2017，170（3）：548-563.e16.

GHOSH S，SINGH R，VANWINKLE Z M，et al. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis[J]. Theranostics，2022，12（12）：5574-5595.

王领. 人参皂苷Rg1抗炎症相关结直肠癌小鼠肿瘤的作用及其机制的研究[D]. 南京：南京中医药大学，2021.

WANG L. Study on the anti-tumor effect and mechanism of ginsenoside Rg1 on inflammation-related colorectal cancer mice[D]. Nanjing：Nanjing University of Chinese Medicine，2021.

XU W Q，LYU W，DUAN C C，et al. Preparation and bioactivity of the rare ginsenosides Rg3 and Rh2：an updated review[J]. Fitoterapia，2023，167：105514.

SERIL D N，LIAO J，YANG G Y，et al. Oxidative stress and ulcerative colitis-associated carcinogenesis：studies in humans and animal models[J]. Carcinogenesis，2003，24（3）：353-362.

王丽. 肠道菌群介导三七皂苷抗炎症性肠病药效及作用机制研究[D]. 长沙：中南大学，2022.

WANG L. Study on the efficacy and mechanism of Panax notoginsenoside against inflammatory bowel disease me- diated by intestinal flora[D]. Changsha：Central South University，2022.

WANG L，SHAO L，CHEN M Y，et al. Effect of ginse- noside compound K on alleviating colitis via modulating gut microbiota[J]. Chin Med，2022，17（1）：146.

JIN S Z，GUAN T X，WANG S，et al. Dioscin alleviates cisplatin-induced mucositis in rats by modulating gut microbiota，enhancing intestinal barrier function and attenua- ting TLR4/NF-κB signaling cascade[J]. Int J Mol Sci，2022，23（8）：4431.

ZHONG Y B，XIAO Q P，HUANG J Q，et al. Ginsenoside Rg1 alleviates ulcerative colitis in obese mice by regula- ting the gut microbiota-lipid metabolism-Th1/Th2/Th17 cells axis[J]. J Agric Food Chem，2023，71（50）：20073-20091.

龚红. 绞股蓝皂苷通过改善肠道屏障功能减轻DSS诱导的小鼠溃疡性结肠炎[D]. 衡阳：南华大学，2022.

GONG H. Gynostemma pentaphyllum saponins alleviate DSS-induced ulcerative colitis in mice by improving intestinal barrier function[D]. Hengyang：University of South China，2022.

FAN L N，XU C C，GE Q W，et al. A. muciniphila suppresses colorectal tumorigenesis by inducing TLR2/NLRP3-mediated M1-like TAMs[J]. Cancer Immunol Res，2021，9（10）：1111-1124.

CHEN L，CHEN M Y，SHAO L，et al. Panax notoginseng saponins prevent colitis-associated colorectal cancer deve- lopment：the role of gut microbiota[J]. Chin J Nat Med，2020，18（7）：500-507.

SHAO L，GUO Y P，WANG L，et al. Effects of ginseno- side compound K on colitis-associated colorectal cancer and gut microbiota profiles in mice[J]. Ann Transl Med，2022，10（7）：408.

NI J J，LI X S，ZHANG H，et al. Mendelian randomization study of causal link from gut microbiota to colorectal cancer[J]. BMC Cancer，2022，22（1）：1371.

刘艳艳，张凯，关家伟，等. 人参皂苷对BALB/c小鼠肠道菌群的影响[J]. 现代生物医学进展，2015，15（6）：1041-1045.

LIU Y Y，ZHANG K，GUAN J W，et al. The effects of ginsenoside on the intestinal microbiota of mice[J]. Prog Mod Biomed，2015，15（6）：1041-1045.

LIAO W L，KHAN I，HUANG G X，et al. Bifidobacterium animalis：the missing link for the cancer-preventive effect of Gynostemma pentaphyllum[J]. Gut Microbes，2021，13（1）：1847629.

GUO Y P，SHAO L，WANG L，et al. Bioconversion variation of ginsenoside CK mediated by human gut microbiota from healthy volunteers and colorectal cancer patients[J]. Chin Med，2021，16（1）：28.

CHEN L，BRAR M S，LEUNG F C，et al. Triterpenoid herbal saponins enhance beneficial bacteria，decrease sulfate- reducing bacteria，modulate inflammatory intestinal microenvironment and exert cancer preventive effects in ApcMin/+ mice[J]. Oncotarget，2016，7（21）：31226-31242.

KHAN I，HUANG G X，LI X A，et al. Mushroom polysaccharides and Jiaogulan saponins exert cancer preventive effects by shaping the gut microbiota and microenvironment in ApcMin/+ mice[J]. Pharmacol Res，2019，148：104448.

HUANG G X，KHAN I，LI X A，et al. Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbio- tic gut microbiota and the intestinal microenvironment in ApcMin/+ mice[J]. Sci Rep，2017，7（1）：12552.

YAO H Q，WAN J Y，ZENG J X，et al. Effects of compound K，an enteric microbiome metabolite of ginseng，in the treatment of inflammation-associated colon cancer[J]. Oncol Lett，2018，15（6）：8339-8348.

周刘华，姚涛，郭爱灵，等. 近十年中药免疫双向调节研究进展[J]. 中国中医基础医学杂志，2020，26（7）：1016-1020，1033.

ZHOU L H，YAO T，GUO A L，et al. Progress in the study of two-way immune regulation of traditional Chinese medicine in recent ten years[J]. Chin J Basic Med Tradit Chin Med，2020，26（7）：1016-1020，1033.

DONG M X，MENG Z F，KUERBAN K，et al. Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota[J]. Cell Death Dis，2018，9（10）：1039.